Evidence map›Paper›PMID 27642597›Full record

ArticleBioMed research international2016

Polyprenols of Ginkgo biloba Enhance Antibacterial Activity of Five Classes of Antibiotics.

Ran Tao, Chengzhang Wang, Jianzhong Ye, Hao Zhou, Hongxia Chen

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. The Potential ofMolecules (Basel, Switzerland) · 2023
    Review
  3. Article
  4. Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  5. Supercritical-COScientific reports · 2021
    Article
  6. Identification ofMolecules (Basel, Switzerland) · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ran TaoInstitute of Chemical Industry of Forest Products, CAF, 16 Suojin Wucun, Nanjing, Jiangsu 210042, China; Research Institute of Forestry New Technology, CAF, Beijing 100091, China.ORCID 0000-0001-7288-2821
Chengzhang WangInstitute of Chemical Industry of Forest Products, CAF, 16 Suojin Wucun, Nanjing, Jiangsu 210042, China; Research Institute of Forestry New Technology, CAF, Beijing 100091, China.ORCID 0000-0001-7863-030X
Jianzhong YeInstitute of Chemical Industry of Forest Products, CAF, 16 Suojin Wucun, Nanjing, Jiangsu 210042, China.
Hao ZhouInstitute of Chemical Industry of Forest Products, CAF, 16 Suojin Wucun, Nanjing, Jiangsu 210042, China; Research Institute of Forestry New Technology, CAF, Beijing 100091, China.
Hongxia ChenInstitute of Chemical Industry of Forest Products, CAF, 16 Suojin Wucun, Nanjing, Jiangsu 210042, China.
Institute of Chemical Industry of Forest Products · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyprenol (GBP) from Ginkgo biloba Leaves (GBL) is an important lipid with many bioactive effects. The effect of GBP on antibacterial properties of five antibiotics belonging to different classes was through analysis of inhibition halos, MIC, and FIC index. And we studied the time-killing curves and Ca(2+) mobilization assay in Staphylococcus aureus cells treated with GBP microemulsion and gentamicin sulfate under MIC/2 conditions. These results showed that the GBP microemulsion (average diameter 90.2 nm) combining with gentamicin sulfate had the highest enhancing antibacterial effect against Staphylococcus aureus, and the MIC value was 33.0 μg/mL. The increase of the antibacterial effect of tested antibiotics was positively correlated with the decrease of the average diameter of GBP microemulsion. Moreover, GBP microemulsion enhanced antibacterial effect and prolonged antibacterial time of GBP combining with gentamicin sulfate against Staphylococcus aureus. GBP microemulsion could enhance the ability of gentamicin inducing an increase in intracellular calcium concentrations to Staphylococcus aureus. GBP microemulsion could help some classes of antibiotics to inhibit or kill bacteria. This study supports the fact that GBP microemulsion obviously can not only reduce the dosage of some classes of antibiotics, but also reduce the frequency of the antibiotic use in vitro.

Indexed as

Anti-Bacterial AgentsDrug SynergismGentamicinsGinkgo bilobaHemiterpenesHumansPentanolsStaphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsGentamicinsHemiterpenesPentanolsprenol

Identifiers

PMID27642597
PMCPMC5011515
OpenAlexW2508247051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.